Back to Search
REID OLDENBURG, MD, PHD
MD, PHD
Dermatology Physician
NPI: 1437647856IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
1437647856(CA)A166384(CA)
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
CMS Specialties
PrimaryDERMATOLOGY
Education
OTHER
Class of 2018
Research & Publications (20)
A genome-wide linkage scan in a Dutch family identifies a premature ovarian failure susceptibility locus.
PMID 18689850·Hum Reprod·2008
8-other
Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.
PMID 18663745·Genes Chromosomes Cancer·2008
8-other
Selective amplification of rare mutations using locked nucleic acid oligonucleotides that competitively inhibit primer binding to wild-type DNA.
PMID 17581615·J Invest Dermatol·2008
8-other
Genetic susceptibility for breast cancer: how many more genes to be found?
PMID 17498966·Crit Rev Oncol Hematol·2007
6-review
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
PMID 16551851·Clin Cancer Res·2006
4-observational
Extending the p16-Leiden tumour spectrum by respiratory tract tumours.
PMID 14985402·J Med Genet·2004
8-other
The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.
PMID 14678969·Cancer Res·2003
8-other
Premature ovarian failure and gene polymorphisms.
PMID 19610175·Curr Opin Obstet Gynecol·2009
6-review
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.
PMID 19576851·Lancet Oncol·2009
3-trial
A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example.
PMID 19563646·BMC Cancer·2009
8-other
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype.
PMID 19338683·Hered Cancer Clin Pract·2009
8-other
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.
PMID 19330027·Nat Genet·2009
8-other
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history.
PMID 19200354·Breast Cancer Res·2009
8-other
Genomewide high-density SNP linkage analysis of non-BRCA1/2 breast cancer families identifies various candidate regions and has greater power than microsatellite studies.
PMID 17760956·BMC Genomics·2007
8-other
A genome wide linkage search for breast cancer susceptibility genes.
PMID 16575876·Genes Chromosomes Cancer·2006
8-other
Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
PMID 15705879·Cancer Res·2005
8-other
Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?
PMID 14871810·Cancer Res·2004
8-other
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations.
PMID 11967536·Nat Genet·2002
8-other
Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium.
PMID 11792833·Proc Natl Acad Sci U S A·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 200 W ARBOR DR
SAN DIEGO, CA 92103 - Phone
- (800) 926-8273
Quick Facts
- NPI
- 1437647856
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 2
- Years in Practice
- 8
- Publications
- 20
Are you this provider?
Claim Your Profile